Pages that link to "Q56524232"
Jump to navigation
Jump to search
The following pages link to Jonathan Beesley (Q56524232):
Displaying 50 items.
- Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot" (Q21144976) (← links)
- Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer (Q24633316) (← links)
- Genome-wide association study identifies novel breast cancer susceptibility loci (Q24645441) (← links)
- Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women (Q24648412) (← links)
- Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers (Q24655824) (← links)
- Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk (Q28385765) (← links)
- Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types (Q28388497) (← links)
- A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. (Q29417084) (← links)
- Common variants at 19p13 are associated with susceptibility to ovarian cancer (Q29417145) (← links)
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (Q30252854) (← links)
- Comparison of 6q25 breast cancer hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (Q31082788) (← links)
- Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics (Q33330850) (← links)
- TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer (Q33566957) (← links)
- Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer (Q33586121) (← links)
- Consequences of germline variation disrupting the constitutional translational initiation codon start sites of MLH1 and BRCA2: Use of potential alternative start sites and implications for predicting variant pathogenicity (Q33700463) (← links)
- A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. (Q33747778) (← links)
- Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium (Q33747831) (← links)
- ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study (Q33824208) (← links)
- Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival (Q33828680) (← links)
- Exploring the link between MORF4L1 and risk of breast cancer (Q33863235) (← links)
- Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium (Q33891803) (← links)
- Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development (Q33901605) (← links)
- Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium (Q33921008) (← links)
- Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium (Q33932856) (← links)
- ABCA transporter gene expression and poor outcome in epithelial ovarian cancer (Q33947899) (← links)
- Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers (Q34031757) (← links)
- Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer (Q34081324) (← links)
- Missense variants in ATM in 26,101 breast cancer cases and 29,842 controls (Q34123806) (← links)
- Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer (Q34126314) (← links)
- HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer (Q34173413) (← links)
- Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk (Q34177267) (← links)
- Confirmation of 5p12 as a susceptibility locus for progesterone-receptor-positive, lower grade breast cancer (Q34181322) (← links)
- Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers (Q34213403) (← links)
- Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 (Q34327945) (← links)
- Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk (Q34342248) (← links)
- Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction (Q34394665) (← links)
- Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium (Q34453723) (← links)
- Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant (Q34522502) (← links)
- Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers (Q34613604) (← links)
- Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer (Q34767345) (← links)
- Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers (Q34801008) (← links)
- Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. (Q34806825) (← links)
- Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. (Q34903062) (← links)
- Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers (Q34949394) (← links)
- Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk (Q34955369) (← links)
- Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium (Q34979715) (← links)
- Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers (Q35022825) (← links)
- Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (Q35064451) (← links)
- Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk (Q35102646) (← links)
- Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium (Q35119701) (← links)